Characterization of P1-deficient isogenic mutant of Haemophilus influenzae biogroup aegyptius associated with Brazilian purpuric fever

Microbial Pathogenesis

Volumn 28, Issue 3, 2000, Pages 145-155

  Segada, Lynn M ^a   Carlone, George M ^d   Gheesling, Linda L ^d   Lesse, Alan J ^a,b,c  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^d NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

Bacterial outer membrane protein; Haemophilus influenzae; Phenotype; Site directed mutagenesis

Indexed keywords

BACTERIAL PROTEIN; OUTER MEMBRANE PROTEIN;

ANIMAL CELL; ARTICLE; BACTERIAL MUTATION; BRAZILIAN PURPURIC FEVER; CYTOTOXICITY; EPITOPE MAPPING; HAEMOPHILUS INFLUENZAE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PURPURA; RAT; STRAIN DIFFERENCE; VASCULAR ENDOTHELIUM;

ANIMALIA; BACTERIA (MICROORGANISMS); HAEMOPHILUS; HAEMOPHILUS AEGYPTIUS; HAEMOPHILUS INFLUENZAE BIOTYPE AEGYPTIUS; NEGIBACTERIA; PURPURA;

EID: 0033821653     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1999.0334     Document Type: Article

References (54)

1. Haemophilus aegyptius bacteraemia in Brazilian purpuric fever
2. Brazilian purpuric fever: Epidemic purpura fulminans associated with antecedent purulent conjunctivitis
3. Brazilian purpuric fever: Haemophilus aegyptius bacteremia complicating purulent conjunctivitis
4. Brazilian purpuric fever: An epidemiologic and clinical summary. The Brazilian Purpuric Fever Study Group Dis
5. Biochemical, genetic, and epidemiologic characterization of Haemophilus influenzae biogroup aegyptius (Haemophilus aegyptius) strains associated with Brazilian purpuric fever
6. Potential virulence-associated factors in Brazilian purpuric fever. Brazilian Purpuric Fever Study Group
7. Stable, conserved outer membrane epitope of strains of Haemophilus influenzae biogroup aegyptius associated with Brazilian purpuric fever
8. DNA sequence analysis and restriction fragment length polymorphisms of the P1 gene of Haemophilus influenzae biogroup aegyptius associated with Brazilian purpuric fever
9. Purification and characterization of a pilin specific for Brazilian purpuric fever-associated Haemophilus influenzae biogroup aegyptius (H. aegyptius) strains
10. Cloning and sequence analysis of the structural pilin gene of Brazilian purpuric fever-associated Haemophilus influenzae biogroup aegyptius
11. Role of the 145-kilodalton surface protein in virulence of the Brazilian purpuric fever clone of Haemophilus influenzae biogroup aegyptius for infant rats
12. Role of lipooligosaccharide in virulence of the Brazilian purpuric fever clone of Haemophilus influenzae biogroup aegyptius for infant rats
13. Comparison of lipopolysaccharides from Brazilian purpuric fever isolates and conjunctivitis isolates of Haemophilus influenzae biogroup aegyptius. Brazilian Purpuric Fever Study Group
14. Brazilian purpuric fever caused by Haentophilus influenzae biogroup aegyptius strains lacking the 3031 plasmid
15. Potential virulence factors of Haemophilus influenzae biogroup aegyptius in Brazilian purpuric fever
16. Insertion sequence IS1016 and absence of Haemophilus capsulation genes in the Brazilian purpuric fever clone of Haemophilus influenzae biogroup aegyptius
17. rRNA gene restriction patterns of Haemophilus influenzae biogroup aegyptius strains associated With Brazilian purpuric fever
18. Expression of an immunoreactive 72 kDa protein in strains of Haemophilus influenzae biogroup aegyptius associated with Brazilian purpuric fever
19. Distinct antigenic and genetic properties of the immunoglobulin A1 protease produced by Haemophilus influenzae biogroup aegyptius associated with Brazilian purpuric fever
20. Distinguishing clonal characteristics of the Brazilian purpuric fever producing strain. The Brazilian Purpuric Fever Study Group
21. Duplication of pilus gene complexes of Haemophilus influenzae biogroup aegyptius
22. mRNA subtractive hybridization for the isolation and identification Of tissue culture induced determinants from Haemophilus influenzae biogroup aegyptius, the causative agent of Brazilian purpuric fever
23. Epidemiology and clinical spectrum of Brazilian purpuric fever. Brazilian Purpuric Fever Study Group
24. Brazilian purpuric fever Mato Grosso, Brazil
25. Brasilian purpuric fever in central Australia
26. Brazilian purpuric fever in Western Australia
27. Suspected Brazilian purpuric fever in a toddler with over whelming Epstein-Barr virus infection
28. Resistance to serum bactericidal activity distinguishes Brazilian purpuric fever (BPF) case strains of Haemophilus influenzae biogroup aegyptius (H. aegyptius) from non-BPF strains
29. Bactericidal activity of human sera against a Brazilian purpuric fever (BPF) strain of Haemophilus influenzae biogroup aegyptius correlates with age-related occurrence of BPF
30. Human microvascular endothelial tissue culture cell model for studying pathogenesis of Brazilian purpuric fever
31. Human microvascular endothelial cell toxicity caused by Brazilian purpuric fever-associated strains of Haemophilus influenzae biogroup aegyptius
32. An infant rat model of bacteremia with Brazilian purpuric fever isolates of Hemophilus influenzae biogroup aegyptius
33. Creation of an isogenic P1-deficient mutant of Haemophilus influenzae biogroup aegyptius
34. Metabolism and evolution of Haemophilus influenzae deduced from a whole-genome comparison with Escherichia coli
35. Role of bacterial Mn-cofactored superoxide dismutase in oxidative stress responses, nasopharyngeal colonization, and sustained bacteremia caused by Haemophilus influenzae type b
36. Molecular and genetic characterization of superoxide dismutase in Haemophilus influenzae type b
37. Lipoprotein e(P4) is essential for hemin uptake by Haemophilus influenzae
38. Identification of the key protein for zinc uptake in Hemophilus influezae
39. In vivo transposon mutagenesis in Haemophilus influenzae
40. Induction and repression of outer membrane proteins by anaerobic growth of Neisseria gonorrhoeae
41. Presence of antibodies to the major anaerobically induced gonococcal outer membrane protein in sera from patients with gonococcal infections
42. Long chain fatty acid transport in Escherichia coli. Cloning, mapping, and expression of the fadL gene
43. Regulation of fatty acid transport in Escherichia coli: Analysis by operon fusion
44. Transport of long chain fatty acids in Escherichia coli. Identification of a membrane protein associated with the fadL gene
45. Transport of long chain fatty acids in Escherichia coli. Evidence for role of fadL gene product as long-chain fatty acid receptor
46. The fadL gene product of Escherichia coli is an outer membrane protein required for uptake of long-chain fatty acids and involved in sensitivity to bacteriophage T2
47. Characterization of FadL-specific fatty acid binding in Escherichia coli
48. Antibodies to Haemophilus influenzae type b outer membrane proteins in children with epiglottitis or meningitis and in healthy controls
49. Expression of the heat-modifiable major outer membrane protein of Haemophilus influenzae type b is unrelated to virulence
50. Isolation and characterization of a mutant of Haemophilus influenzae type b deficient in outer membrane protein P1
51. Isolation by streptonigrin enrichment and characterization of a transferrin-specific iron uptake mutant of Neisseria meningitidis
52. Nutritional profiles of Neisseria gonorrhoeae, Neisseria meningitidis, and Neisseria lactamica in chemically defined media and the use of growth requirments for gonococcal typing
53. Genetic evidence that Neisseria gonorrhoeae produces specific receptors for transferrin and lactoferrin
54. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa